How much funding has Synthekine raised?

Synthekine has raised $289.5M in total funding, most recently a Series C round.

Who are Synthekine's investors?

Synthekine's investors include The Column Group, Deerfield Management, Janus Henderson Investors, Canaan Partners, Samsara BioCapital.

When was Synthekine founded?

Synthekine was founded in 2019.

Where is Synthekine headquartered?

Synthekine is headquartered in Menlo Park, California, United States.

What industry is Synthekine in?

Synthekine operates in Biotech, Healthcare.

How many employees does Synthekine have?

Synthekine has 51-200 employees.

Synthekine

Cytokines by Design

Menlo Park, United States · Founded 2019 · $289.5M raised

Biotech

Healthcare

Headquarters: Menlo Park, California
Employees: 51–200
Founded: 2019
Business Model: B2B

Website: synthekine.com
Total Funding: $289.5M
Last Round: $100.0M Series CSep 2023
Rounds: 3

About

Biotechnology company engineering novel cytokines to advance immunology and develop next-generation therapeutics.

Summary

Synthekine is a Biotech company based in Menlo Park, United States, founded in 2019. It has raised $289.5M in total across 3 rounds, most recently a $100.0M Series C round in Sep 2023. Investors include The Column Group, Deerfield Management and Janus Henderson Investors.

X (Twitter)